Search Results
Mar 17, 2026, 09:00 ET SLICKBAR® WINS DUAL HONOURS AT THE GLOBAL BRAND AWARDS 2025
Brands Magazine (GBM), is a testament to SLICKBAR®'s progress as an international brand. This recognition highlights our manufacturing capabilities, product quality, and commitment to innovation and customer-focused solutions. These awards acknowledge SLICKBAR®'s strength in the industry and serve as motivation
More news about: Global Brands Magazine
Mar 17, 2026, 09:00 ET For Texas Ranchers Fighting Invasive Brush, XAG Drones Are Changing the Odds
plants, and know when and how to treat them. "All those techniques I grew up learning turned out to be something I needed when I was in my late 40s and early 50s," he laughs. "Here I am doing this."For Schramm, the work has always been about more than brush. "If you're in a drought, you need to feed
More news about: XAG
Mar 17, 2026, 09:00 ET Stern Cardiovascular and Atria Health Announce Strategic Partnership to Expand Advanced, Physician-Led Cardiac Care Across the Mid-South
high-quality, patient-centered cardiovascular care – while remaining physician-led and independent," said Stern Cardiovascular Cardiologist and President Steven S. Gubin, MD, FACC. "With Atria's support, we can bring new technologies and services to our communities faster, recruit additional physicians and meet
More news about: Atria Health Opco Inc.
Mar 17, 2026, 09:00 ET APO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Apollo Global management, Inc. Securities Lawsuit -- The Gross Law Firm
and/or failed to disclose that: (1) defendants, among other leadership figures at Apollo Global, frequently communicated with Jeffrey Epstein in the 2010s regarding Apollo Global's business; (2) as a result, Apollo Global's assertion that the Company had never done business with Jeffrey Epstein was untrue;
More news about: The Gross Law Firm
Mar 17, 2026, 09:00 ET INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm
Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107's overall regulatory and commercial prospects were overstated; and (v) as a result, defendants' public statements were materially false and misleading
More news about: The Gross Law Firm
Mar 17, 2026, 09:00 ET RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit -- The Gross Law Firm
Mucopolysaccharidosis Type I, also known as Hurler syndrome. Defendants' statements included, among other things, REGENXBIO's positive assertions of RGX-111's future trial success based on continuing positive biomarker and safety data from the ongoing PhaseI/II study. 3. Defendants provided these overwhelmingly
More news about: The Gross Law Firm
Mar 17, 2026, 09:00 ET Optro launches AI-Powered GRC Capabilities for the Modern Enterprise with AI Governance, Cyber Risk, and Continuous Control Monitoring
optro.ai or stop by booth S-1749 at the RSAC Conference in San Francisco next week.About Optro Optro (formerly AuditBoard) helps enterprises transform risk
More news about: Optro, Inc
Mar 17, 2026, 09:00 ET Philips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behind
Diamond Clean range + A3 brush head, in hard-to-reach areas vs. a manual toothbrush in 6 weeks. 3 Philips Sonicare 6500 Range + C3 or S2 brush head, in hard-to-reach areas vs. a manual toothbrush in 6 weeks.About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA)
More news about: Philips Sonicare
Mar 17, 2026, 09:00 ET ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer's Precision Medicine Worldwide
successful in cancer treatment."About The Alzheimer's Drug Discovery Foundation (ADDF)Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the development of drugs to prevent, treat, and cure Alzheimer's
More news about: Alzheimer's Drug Discovery Foundation
Mar 17, 2026, 08:58 ET Dr. Ryan S. Diederich Named Medical Staff President of Anderson Hospital
MARYVILLE, Ill., March 17, 2026 /PRNewswire/ -- Dr. Ryan S. Diederich from MidAmerica Plastic Surgery & Medical Spa has been named Medical Staff President of Anderson Hospital, effective January 1, 2026.
More news about: MidAmerica Plastic Surgery & Medical Spa
Mar 17, 2026, 08:38 ET X3 Tradesmen Launches National Division to Expand Electrician, Plumbing, and HVAC Staffing Across 49 States
company has supported more than 7,000 construction projects and deploys over 1,200 skilled tradespeople annually.The new National Division extends X3's established model nationwide and is powered by
More news about: X3 Tradesmen
Mar 17, 2026, 08:30 ET A2GOLD IDENTIFIES DISTRICT SCALE ANTIMONY POTENTIAL AT THE TAYLOR SILVER-GOLD PROJECT IN NEVADA
Mine and Merrimac Mine.The Enterprise Mine operated during the late 1930s through the early 1940s.The Merrimac Mine operated during the late 1950s through the early 1960s.Historical records indicate the Enterprise Mine produced sorted, high-grade antimony
More news about: A2 Gold Corp
Mar 17, 2026, 08:29 ET SSAB's Annual Report 2025 is published
https://news.cision.com/ssab/r/ssab-s-annual-report-2025-is-published,c4322375The following files are available for download:
More news about: SSAB
Mar 17, 2026, 08:26 ET Fox ESS lanceert Intelligent Power Q op Solar Solutions Amsterdam en herdefinieert normen voor energieopslag
energieopslag. Het bedrijf realiseert daar bijna 10.000 installaties per maand en bereikte een piek van bijna 500 MWh in één maand. In 2025 erkende de S&P Global Energy Residential Storage Index Fox ESS als marktleider qua marktaandeel in Europa, Polen en het Verenigd Koninkrijk voor de eerste helft van
More news about: Fox ESS
Mar 17, 2026, 08:06 ET RMX Industries, Inc. Announces Confidential Submission of Draft S-1 Registration Statement to the U.S. Securities and Exchange Commission
RMX Industries, Inc. ("RMX" or the "Company") (OTCQB: RMXI) today announced that it has confidentially submitted a draft registration statement on Form S‑1 to the U.S. Securities and Exchange Commission (the "SEC") relating to the resale of shares of the Company's Class A Common Stock by the selling stockholders
More news about: RMX Industries, Inc.
Mar 17, 2026, 08:00 ET Dahua Technology predstavuje riešenia ITS s podporou AI na veľtrhu Intertraffic 2026
zaznamenáva vysokokvalitné dôkazy na účely presadzovania práva s modulárnou spoľahlivosťou za každého počasia.Spotter Ultra – Osempruhový systém detekcie prekročenia rýchlosti a dopravných priestupkov 24 hodín denne, 7 dní v týždni s kompletným reťazcom dôkazov, ideálny pre zložité križovatky.iPatrol
More news about: Dahua Technology
Mar 17, 2026, 08:00 ET Scale Computing™ Dominates Server Virtualization and Hyperconverged Infrastructure in G2's Spring 2026 Report
"Earning 40 badges in G2's Spring 2026 report is a powerful testament to the trust our customers place in us, and to our team's relentless commitment to innovation," said Craig
More news about: Scale Computing
Mar 17, 2026, 08:00 ET Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
development, regulatory and commercial milestone payments of up to low triple-digit millions of U.S. dollars, and Alebund will share in the economics of AP306's success in the R1 Territory through tiered royalty payments in the low double-digit percentage range on net sales. In addition, Alebund holds a substantial
More news about: Alebund Pharmaceuticals
Mar 17, 2026, 08:00 ET CrownPoint Partners Brokers Sale of Two Tuffy Tire & Auto Service Properties in Toledo, Ohio
[email protected] Office Locations260 Newport Center Drive, Suite 100 | Newport Beach, CA 92660700 S Rosemary Square, Suite 204 | West Palm Beach, FL 33401
More news about: CrownPoint Partners
Mar 17, 2026, 08:00 ET Virtusa Named a Global Leader on the 2025 CDP Climate A List
US$127 trillion) use CDP data to help inform investment and lending decisions.Rigorous alignment: Aligned with the ISSB's climate standard, IFRS S2, as its foundational baseline, CDP integrates best practice reporting standards and frameworks.Virtusa's 'A' rating reflects three core pillars
More news about: Virtusa Corporation
Mar 17, 2026, 07:52 ET Jaguar Uranium Initiates Rare Earth Element Assessment at Colombia's Berlin Project
__________________________1 Jaguar Uranium Corp. Form S-1 (January 9, 2026) – Berlin Project – Caldas Province, Colombia https://www.sec.gov/Archives/edgar/data/2039273/000121390026002880/ea0219487-15.htm#TOC001Western
More news about: Jaguar Uranium
Mar 17, 2026, 07:43 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
trial with CS014. The pharmacokinetic comparison allows Cereno Scientific to leverage the extensive clinical experience with VPA to strengthen the CS014's safety package. A successful trial is expected to remove the need for additional nonclinical safety studies and a clinical Phase IIa trial, allowing
More news about: Cereno Scientific
Mar 17, 2026, 07:39 ET Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD
trial with CS014. The pharmacokinetic comparison allows Cereno Scientific to leverage the extensive clinical experience with VPA to strengthen the CS014's safety package. A successful trial is expected to remove the need for additional nonclinical safety studies and a clinical Phase IIa trial, allowing
More news about: Cereno Scientific
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México
Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol 2013;31:3272-3278.Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil
https://www.orpha.net/en/disease/detail/545Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren
More news about: Knight Therapeutics Inc.